ClinConnect ClinConnect Logo
Search / Trial NCT06569940

Sleepiz One+ vs. Capnography and Electrocardiography

Launched by SLEEPIZ AG · Aug 23, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is comparing two different methods for measuring important health signs: the Sleepiz One+ device and traditional methods like capnography (which measures carbon dioxide in your breath) and electrocardiography (which tracks your heart's rhythm). The goal is to see how well these methods measure breathing and heart rates, especially in people with chronic conditions like asthma, COPD, diabetes, and high blood pressure, as well as in healthy adults. Monitoring these vital signs is important because changes can indicate worsening health, and catching these changes early can lead to better care.

To participate in this study, you need to be at least 18 years old. You can join if you have one or more chronic medical conditions, or if you are a healthy volunteer with no chronic conditions. However, if you have certain medical devices like a pacemaker, are pregnant or breastfeeding, or have difficulty following study procedures, you won't be eligible. Participants will be asked to provide consent and will be monitored in a clinical setting while at rest. This is a great opportunity to contribute to research that could improve monitoring for many patients in the future!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients:
  • Age \>=18years
  • Informed Consent as documented by signature
  • One (or more) chronic medical condition/s (e.g., diabetes, asthma, cardiovascular or respiratory diseases, etc.)
  • Healthy volunteers
  • Age \>=18years
  • Informed Consent as documented by signature
  • No diagnosed chronic medical condition
  • Exclusion Criteria:
  • Patients
  • Previous enrolment into the current study,
  • Cardiac pacemaker or another implanted electrical device
  • Women who are pregnant or breastfeeding
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
  • Healthy volunteers:
  • Previous enrolment into the current study,
  • Cardiac pacemaker or another implanted electrical device
  • Women who are pregnant or breastfeeding
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
  • Presence of diagnosed chronic medical condition

About Sleepiz Ag

Sleepiz AG is an innovative healthcare company dedicated to advancing sleep medicine through cutting-edge technology and research. Specializing in the development of non-invasive diagnostic tools, Sleepiz AG focuses on improving the assessment and treatment of sleep disorders. With a commitment to enhancing patient outcomes, the company conducts rigorous clinical trials to validate its solutions, aiming to provide healthcare professionals with reliable, data-driven insights into sleep health. By leveraging its expertise in sleep science and technology, Sleepiz AG strives to transform the landscape of sleep diagnostics and contribute to the overall well-being of individuals affected by sleep-related issues.

Locations

Zürich, Zurich, Switzerland

Patients applied

0 patients applied

Trial Officials

Christian Neumann, Dr. med.

Principal Investigator

Zentrum für Schlafmedizin "Schlaflabor Fluntern"

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported